| (2R,2R)-PF-07258669 |
|
|
|
|
|
99.64% |
| (D-Phe7)-α-MSH |
|
|
|
|
|
|
| (E/Z)-Resomelagon acetate |
|
|
|
|
|
|
| (Nle4)-α-MSH |
|
|
|
|
|
|
| (p-Iodo-Phe7)-ACTH (4-10) |
|
|
|
|
|
|
| (Phe2,Nle4)-ACTH (1-24) (human, bovine, rat) |
|
|
|
|
|
|
| (R)-Lirinidine |
|
|
|
|
|
|
| (±)-Eriodictyol |
|
|
|
|
|
99.9% |
| 1,7-Bis(4-hydroxyphenyl)-hepta-4E,6E-dien-3-one |
|
|
|
|
|
|
| 18-Hydroxy-11-deoxy corticosterone |
|
|
|
|
|
|
| 6-Methoxy-4-methylcoumarin |
|
|
|
|
|
99.00% |
| [D-Trp8]-γ-MSH |
|
|
|
|
|
98.25% |
| [D-Trp8]-γ-MSH TFA |
|
|
|
|
|
|
| Ac-(d-Arg)-CEH-(d-Phe)-RWC-NH2 |
|
|
|
|
|
99.96% |
| Ac-c[Cys-Glu-His-d-Phe-Arg-Trp-d-Cys]-Pro-Pro-Lys-Asp-NH2 |
|
|
|
|
|
98.14% |
| Acetyl hexapeptide-1 |
|
|
|
|
|
99.43% |
| Acetyl hexapeptide-1 acetate |
|
|
|
|
|
99.47% |
| ACTH (1-16) (human) |
|
|
|
|
|
99.87% |
| ACTH (1-17) |
|
|
|
|
|
|
| ACTH (1-17) TFA |
|
|
|
|
|
99.79% |
| ACTH (11-24) |
|
|
|
|
|
99.99% |
| ACTH (11-24) acetate |
|
|
|
|
|
99.88% |
| ACTH (22-39) |
|
|
|
|
|
99.87% |
| ACTH (3-24) (human, bovine, mouse, ovine, porcine, rabbit, rat) |
|
|
|
|
|
|
| ACTH (34-39) |
|
|
|
|
|
99.88% |
| ACTH (4-11) |
|
|
|
|
|
98.48% |
| ACTH (4-9) |
|
|
|
|
|
|
| ACTH (7-38) (human) |
|
|
|
|
|
99.57% |
| Adrenocorticotropic hormone (1-39), rat |
|
|
|
|
|
99.31% |
| Adrenocorticotropic hormone (1-39), rat TFA |
|
|
|
|
|
99.84% |
| Adrenocorticotropic Hormone (ACTH) (1-10), human |
|
|
|
|
|
98.26% |
| Adrenocorticotropic Hormone (ACTH) (1-39), human |
|
|
|
|
|
99.94% |
| Adrenocorticotropic Hormone (ACTH) (4-10), human |
|
|
|
|
|
99.18% |
| Agouti-Related Protein (54-82) (human) |
|
|
|
|
|
|
| Agouti-related Protein (AGRP) (83-132) Amide (human) |
|
|
|
|
|
|
| Agouti-related Protein (AGRP) (83-132) Amide (human) TFA |
|
|
|
|
|
95.41% |
| Albocycline K3 |
|
|
|
|
|
|
| ALD1613 |
|
|
|
|
|
|
| Alsactide |
|
|
|
|
|
|
| Amphistin |
|
|
|
|
|
|
| ATMW-2 |
|
|
|
|
|
|
| Bivamelagon |
|
|
|
|
|
99.19% |
| Bivamelagon hydrochloride |
|
|
|
|
|
|
| Bivamelagon-d8 |
|
|
|
|
|
|
| BMS-470539 |
|
|
|
|
|
|
| BMS-470539 dihydrochloride |
|
|
|
|
|
99.85% |
| Bremelanotide |
|
|
|
|
|
99.69% |
| Cadin-1(14)-ene-7a,11-diol |
|
|
|
|
|
|
| CCZ01048 |
|
|
|
|
|
|
| CCZ01048 TFA |
|
|
|
|
|
98.54% |
| CD08108 |
|
|
|
|
|
|
| Chlorophorin |
|
|
|
|
|
|
| Codactide |
|
|
|
|
|
|
| CTX-1211 |
|
|
|
|
|
|
| Defensin HNP 4 |
|
|
|
|
|
|
| Defensin NP-3A |
|
|
|
|
|
|
| Dersimelagon |
|
|
|
|
|
98.10% |
| Dersimelagon phosphate |
|
|
|
|
|
|
| DOTA-GGNle-CycMSHhex |
|
|
|
|
|
|
| Ebiratide |
|
|
|
|
|
|
| Filimelnotide |
|
|
|
|
|
|
| Filimelnotide acetate |
|
|
|
|
|
|
| GPS1573 |
|
|
|
|
|
99.37% |
| hMC1R agonist 1 |
|
|
|
|
|
|
| HS014 |
|
|
|
|
|
|
| HS014 TFA |
|
|
|
|
|
98.84% |
| HS024 |
|
|
|
|
|
|
| HS024 TFA |
|
|
|
|
|
99.80% |
| IIIM-8 |
|
|
|
|
|
|
| JKC363 |
|
|
|
|
|
99.06% |
| JKC363 TFA |
|
|
|
|
|
|
| JLB2-110c |
|
|
|
|
|
|
| JNJ-10229570 |
|
|
|
|
|
98.0% |
| JNJ-10229570 (Standard) |
|
|
|
|
|
|
| Lys-γ3-MSH(human) |
|
|
|
|
|
|
| Lys-γ3-MSH(human) TFA |
|
|
|
|
|
97.44% |
| MC-4R Agonist 1 |
|
|
|
|
|
|
| MC1R Human Pre-designed siRNA Set A |
|
|
|
|
|
|
| Mc1r Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
| MC1R Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
| MC2R Human Pre-designed siRNA Set A |
|
|
|
|
|
|
| Mc2r Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
| Mc2r Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
| MC3R Human Pre-designed siRNA Set A |
|
|
|
|
|
|
| Mc3r Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
| Mc3r Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
| MC4-NN2-0453 |
|
|
|
|
|
99.15% |
| MC4R Antagonist-1 |
|
|
|
|
|
|
| MC4R antagonist-2 |
|
|
|
|
|
|
| MC4R antagonist-3 |
|
|
|
|
|
|
| MC4R Human Pre-designed siRNA Set A |
|
|
|
|
|
|
| Mc4r Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
| Mc4r Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
| MC5R Human Pre-designed siRNA Set A |
|
|
|
|
|
|
| Mc5r Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
| Mc5r Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
| MCL-0129 |
|
|
|
|
|
|
| MCL0020 |
|
|
|
|
|
99.93% |
| Melanocin A |
|
|
|
|
|
|
| Melanostatin, frog |
|
|
|
|
|
|
| Melanotan (MT)-II acetate |
|
|
|
|
|
|
| Melanotan I acetate |
|
|
|
|
|
98.96% |
| Melanoxazal |
|
|
|
|
|
|
| MK-0489 |
|
|
|
|
|
|
| MK-0493 |
|
|
|
|
|
98.19% |
| MK-0493 hydrochloride |
|
|
|
|
|
98.76% |
| ML-00253764 hydrochloride |
|
|
|
|
|
99.29% |
| ML00253764 |
|
|
|
|
|
99.71% |
| Modimelanotide |
|
|
|
|
|
|
| Modimelanotide acetate |
|
|
|
|
|
|
| MPCI |
|
|
|
|
|
|
| MSG606 |
|
|
|
|
|
99.68% |
| MSG606 TFA |
|
|
|
|
|
|
| N,N′-Diferuloylputrescine |
|
|
|
|
|
97.0% |
| Neuropeptide EI, rat |
|
|
|
|
|
|
| ORG 31433 |
|
|
|
|
|
|
| ORG-2766 |
|
|
|
|
|
|
| Palmitoyl tetrapeptide-20 |
|
|
|
|
|
99.21% |
| Palmitoyl tetrapeptide-20 TFA |
|
|
|
|
|
|
| PF-00446687 free base |
|
|
|
|
|
98.02% |
| PF-00446687 hydrochloride |
|
|
|
|
|
|
| PF-07258669 |
|
|
|
|
|
98.44% |
| PG-901 |
|
|
|
|
|
99.35% |
| PG-911 |
|
|
|
|
|
|
| PG-931 |
|
|
|
|
|
99.60% |
| PG-931 TFA |
|
|
|
|
|
|
| PG106 |
|
|
|
|
|
|
| PG106 TFA |
|
|
|
|
|
98.42% |
| PRAME peptide (425-433) acetate |
|
|
|
|
|
98.16% |
| Resomelagon |
|
|
|
|
|
98.79% |
| Resomelagon acetate |
|
|
|
|
|
99.15% |
| Resomelagon methanesulfonate |
|
|
|
|
|
|
| RO27-3225 |
|
|
|
|
|
|
| RO27-3225 TFA |
|
|
|
|
|
98.65% |
| RY764 |
|
|
|
|
|
|
| Scytalol A |
|
|
|
|
|
|
| Setmelanotide |
|
|
|
|
|
99.99% |
| Setmelanotide monoacetate |
|
|
|
|
|
99.81% |
| Setmelanotide TFA |
|
|
|
|
|
|
| SHU 9119 |
|
|
|
|
|
99.83% |
| SNT-207707 |
|
|
|
|
|
99.54% |
| SNT-207858 |
|
|
|
|
|
|
| SNT-207858 free base |
|
|
|
|
|
99.66% |
| TCMCB07 |
|
|
|
|
|
99.86% |
| TCMCB07 TFA |
|
|
|
|
|
99.69% |
| Tetracosactide acetate |
|
|
|
|
|
99.35% |
| THIQ |
|
|
|
|
|
98.48% |
| Undecylenoyl phenylalanine |
|
|
|
|
|
95.0% |
| α-MSH (11-13) |
|
|
|
|
|
|
| α-MSH (11-13) acetate |
|
|
|
|
|
99.31% |
| α-MSH free acid |
|
|
|
|
|
|
| α-MSH TFA |
|
|
|
|
|
98.54% |
| α-MSH |
|
|
|
|
|
99.98% |
| β-Corticotropin (swine) |
|
|
|
|
|
|
| β-Melanocyte Stimulating Hormone (MSH), human |
|
|
|
|
|
99.80% |
| β-Melanocyte Stimulating Hormone (MSH), human TFA |
|
|
|
|
|
98.16% |
| γ-1-Melanocyte Stimulating Hormone (MSH), amide |
|
|
|
|
|
97.03% |
| γ-2-MSH (41-58), amide |
|
|
|
|
|
98.16% |
| γ1-MSH |
|
|
|
|
|
99.60% |
| γ1-MSH TFA |
|
|
|
|
|
|
| γ3-MSH |
|
|
|
|
|
|
| δ-MSH |
|
|
|
|
|
|
| Nonapeptide-1 |
|
|
|
|
|
98.74% |
| Nonapeptide-1 acetate salt |
|
|
|
|
|
95.58% |
| Terrein |
|
|
|
|
|
99.44% |
| Eriodictyol |
|
|
|
|
|
99.55% |
| (-)-Isodocarpin |
|
|
|
|
|
99.78% |
| Tetracosactide |
|
|
|
|
|
99.46% |
| Melanotan (MT)-II |
|
|
|
|
|
99.97% |
| Melanotan I |
|
|
|
|
|
99.04% |
| Fenoprofen |
|
|
|
|
|
99.70% |
| Fenoprofen-13C6 sodium hydrate |
|
|
|
|
|
|
| Delmadinone acetate |
|
|
|
|
|
|
| Bremelanotide Acetate |
|
|
|
|
|
99.94% |
| Fenoprofen Calcium |
|
|
|
|
|
|
| Fenoprofen Calcium hydrate |
|
|
|
|
|
99.52% |